Home Home Home Inbox Home Search

Event

Cefiderocol (S-649266) for Nosocomial Pneumonia Caused by Gram-Negative Pathogens: Study Design of APEKS-NP, a Phase 3 Double-Blind Parallel-Group Randomized Clinical Trial [Board No. P454]

Location: Board no. P454
Session Type: Thematic Poster Session
Monday
May
21
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Takayuki Katsube

PhD
Shionogi & Co., Ltd.

Tsutae Den Nagata

MD
Shionogi Inc

Mari Ariyasu

PhD
Shionogi & Co., Ltd.

Yuko Matsunaga

MD
Shionogi Inc

Yoshinori Yamano

PhD
Shionogi & Co., Ltd.

Roger Echols

MD
ID3C LLC

View Abstract

Cefiderocol (S-649266) for Nosocomial Pneumonia Caused by Gram-Negative Pathogens: Study Design of APEKS-NP, a Phase 3 Double-Blind Parallel-Group Randomized Clinical Trial

Parent Sessions

  • B42 - CRITICAL CARE: THE FEVER - INFECTIONS IN THE ICU...
    05-21-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search